News Express: UM Macao Centre for Testing of Chinese Medicine holds promotion event
新聞快訊:澳大澳門中藥檢測中心辦業界推介會
澳大澳門中藥檢測中心舉辦業界推介會
The UM Macao Centre for Testing of Chinese Medicine holds a promotion event
澳大澳門中藥檢測中心辦業界推介會
澳門大學澳門中藥檢測中心今(18)日舉辦首場業界推介會,藉此加強與業界聯繫,推動中藥大健康產業的發展,為澳門經濟適度多元注入新的技術支撐。
推介會開幕式上,澳門特區政府藥物監督管理局副局長李世恩、澳門大學副校長葛偉分別致辭。李世恩表示:“藥物檢驗是藥物監督管理工作的重要基石。通過科學嚴謹的檢測手段,能夠有效監控藥物質量,從而保障市民用藥的安全;更重要的是,完善的藥物檢驗體系能增強社會各界對澳門藥物及中藥產品的信心。期望透過第三方中藥檢測的合作,與澳大澳門中藥檢測中心共同努力,賦能中藥創新發展,助力推動澳門的中醫藥大健康產業。”
葛偉感謝相關政府部門、行業協會、企業廠商代表參加推介會,並對檢測中心成立以來的工作給予充分肯定,以及提出進一步期望。他表示,澳大將一如既往以推動澳門特區經濟適度多元為己任,大力支持檢測中心的工作與發展。
澳大澳門中藥檢測中心主任李紹平感謝澳門特區政府、澳大和社會各界對檢測中心建設的支持與關注。他介紹了檢測中心的建設情況、技術特色和發展目標,表示檢測中心將秉持“科學公正、嚴謹求實、優質高效、不斷改進”的質量宗旨,在中藥檢測方面,做澳門質量守護者;在中藥研究方面,做國際標準制定者;在中藥認證方面,做優質產品鑒定者,為澳門中藥註冊與市場中藥質量監管提供高質量的技術支持。
會上,檢測中心綜合部介紹了澳大澳門中藥檢測中心提供的服務範圍、收費標準及客戶服務平台使用,客戶可以透過MYLIMS電子平台進行諮詢、提交委託、查詢,流程操作簡單。會後,嘉賓還參觀了檢測中心實驗室,進一步交流探討檢測合作。
澳門中聯辦教育與青年工作部處長岑嘉儀、澳門特區政府衛生局代副局長呂綺玲、澳門特區政府經濟及科技發展局代廳長翁年輝、澳門科學技術發展基金行政委員會委員鄭冠偉、澳門招商投資促進局高級經理周鵬,澳大中華醫藥研究院副院長兼澳門中藥研發中心主任李鵬、健康科學學院助理院長狄利俊、澳門轉化醫學創新研究院代副院長趙永華,匯彩控股有限公司主席陳捷、澳門醫務界聯合總會理事長關秉權、澳門中藥業公會會長關樹權、南粵天然藥物有限公司生產運營總監梁志明等60多位嘉賓出席推介會。
自成立以來,澳大澳門中藥檢測中心致力充分發揮澳門優勢和技術特色,以“立足國際標準,發展澳門檢測,實現澳門認證,助力澳門中藥產業化和國際化發展”為目標,加強中藥檢測的特色項目開發和研究成果的應用轉化,發揮中藥國際標準制定優勢,為“澳門製造”、“澳門監造”和“澳門監製”賦予“澳門質量”內涵,為澳門中藥品牌建立和發展提供有力的技術支持和保障。
澳大澳門中藥檢測中心是澳門藥監局指定第三方檢測機構,也是澳門生產力暨科技轉移中心代送外檢測服務合作機構。截至2024年底,中心已有近120項檢測獲得中國合格評定國家認可委員會(CNAS)認可,基本覆蓋《中國藥典》中藥檢測能力要求,竭力為客戶提供優質高效、智能化的服務。未來,檢測中心的專業團隊將不斷提升檢測能力,以服務澳門中藥產業為己任,致力打造粵港澳大灣區質量檢測認證高地。
欲瀏覽官網版可登入以下連結:
https://www.um.edu.mo/zh-hant/news-and-press-releases/press-release/detail/60368/
UM Macao Centre for Testing of Chinese Medicine holds promotion event
The Macao Centre for Testing of Chinese Medicine (MCTCM) of the University of Macau (UM) held its first promotion event today (18 February), with the aim of strengthening connections with the industry, promoting the development of the Chinese medicine and ‘big health’ industries, and providing technical support for Macao’s economic diversification. More than 60 government officials and industry practitioners attended the event.
Speaking at the opening ceremony, Lei Sai Ian, vice president of the Pharmaceutical Administration Bureau of the Macao SAR Government, said that ‘Drug testing and inspection are fundamental cornerstones of pharmaceutical supervision and management. Through scientifically rigorous testing methods, we can effectively monitor the quality of medicines and ensure the safety of our citizens’ medication. More importantly, a well-established drug inspection system can enhance public confidence in local drugs and traditional Chinese medicine products. By collaborating with third-party testing services, we aim to work with the Macao Centre for Testing of Chinese Medicine to support the innovative development of Chinese medicine and promote the health industry in Macao.’
Ge Wei, vice rector of UM, mentioned that UM will continue to promote the economic diversification of the Macao SAR and support the work and development of MCTCM.
Li Shaoping, director of UM MCTCM, gave an overview of the centre’s development, technical features, and development goals. He said that MCTCM will provide high-quality technical support for the registration of Chinese medicines in Macao and the quality control of Chinese medicines in the market.
The Department of General Management of UM MCTCM also introduced the centre’s range of services and fees, as well as its customer service platform. Through the MyLIMS electronic platform, clients can consult, submit requests, and make enquiries. After the event, the participants visited the centre’s laboratory and had further discussions on cooperation.
Also present at the event were: Cen Jiayi, director of the Department of Education and Youth Affairs of the Liaison Office of the Central People’s Government in the Macao SAR; Loi I Leng, acting deputy director of the Health Bureau of the Macao SAR Government; Iong Nin Fai, acting department head of the Economic and Technological Development Bureau of the Macao SAR Government; Cheang Kun Wai, member of the Administrative Committee of the Science and Technology Development Fund of Macao; Chao Pang, senior manager of the Commerce and Investment Promotion Institute of Macao; Li Peng, deputy director of the UM Institute of Chinese Medical Sciences and director of the UM Macao Centre for Research and Development in Chinese Medicine; Di Lijun, assistant dean of the UM Faculty of Health Sciences; Zhao Yonghua, interim associate head of the Macau Institute for Translational Medicine and Innovation, UM; Jay Chun, chairman of Paradise Entertainment Limited; Kuan Peng Kun, executive director of the Macau Medical and Health Federation; Kuan Su Kun, president of the Macau Chinese Medicine Industry Guild, Kuan Su Kun; and Liang Zhiming, director of production operations of Nan Yue Natural Medicine Co Limited.
Since its establishment, UM MCTCM has been committed to fully leveraging Macao’s strengths and technical characteristics. Its goal is to ‘base itself on international standards, develop Macao testing, achieve Macao certification, and assist in the industrialisation and internationalisation of Macao’s Chinese medicine’. The centre focuses on promoting the development of specialised projects in Chinese medicine testing and the application of research results. It aims to utilise its strengths in establishing international standards for Chinese medicine to create a connotation of ‘Macao quality’ of ‘products made in Macao’, ‘products inspected by Macao’, and ‘products supervised by Macao’, thereby providing strong technical support and guarantees for the establishment and development of Macao’s Chinese medicine brands.
UM MCTCM is a third-party testing institution designated by the Pharmaceutical Administration Bureau (ISAF) of the Macao SAR Government and also serves as a cooperative institution for external testing services through the Macau Productivity and Technology Transfer Center (CPTTM). As of the end of 2024, nearly 120 testing items of the centre have been accredited by the China National Accreditation Service for Conformity Assessment (CNAS), covering most of the requirements for traditional Chinese medicine testing capabilities as outlined in the Chinese Pharmacopoeia. MCTCM will provide high-quality, efficient, and intelligent services to its clients. The team at the centre will also continuously enhance its testing capabilities with a commitment to serving Macao’s Chinese medicine industry and establishing a hub for quality testing certification in the Guangdong-Hong Kong-Macao Greater Bay Area.
To read the news on UM’s official website, please visit the following link:
https://www.um.edu.mo/news-and-press-releases/press-release/detail/60368/